Clinical Proteomics

Papers
(The TQCC of Clinical Proteomics is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets59
Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies33
Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers26
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables22
Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy21
The use of proteomics for blood biomarker research in premature infants: a scoping review21
Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma20
Serum proteomics of severe fever with thrombocytopenia syndrome patients20
Kinase inhibitor pulldown assay (KiP) for clinical proteomics20
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection18
Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line18
Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders17
Many kinds of oxidized proteins are present more in the urine of the elderly17
sBioSITe enables sensitive identification of the cell surface proteome through direct enrichment of biotinylated peptides17
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response16
Changes in amino acid concentrations and the gut microbiota composition are implicated in the mucosal healing of ulcerative colitis and can be used as noninvasive diagnostic biomarkers15
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals14
Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins14
13C15N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans13
Systematic evaluation and optimization of protein extraction parameters in diagnostic FFPE specimens13
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers13
Characterizing age-related changes in intact mitochondrial proteoforms in murine hearts using quantitative top-down proteomics13
Redefining serological diagnostics with immunoaffinity proteomics12
Proteome profiling of human placenta reveals developmental stage-dependent alterations in protein signature12
Change of histone H3 lysine 14 acetylation stoichiometry in human monocyte derived macrophages as determined by MS-based absolute targeted quantitative proteomic approach: HIV infection and methamphet11
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers11
The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study11
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics10
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients9
Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry9
Development of an ID-LC–MS/MS method using targeted proteomics for quantifying cardiac troponin I in human serum9
Label-free LC–MS/MS proteomics analyses reveal proteomic changes in oxidative stress and the SOD antioxidant strategy in TM cells8
Recent progress in mass spectrometry-based urinary proteomics8
Changes of serum IgG glycosylation patterns in rheumatoid arthritis8
Label-free quantitative proteomic analysis of serum exosomes from patients of renal anemia: The Good and the Bad of Roxadustat8
Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers8
Comment on “Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics”7
Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma7
Resistin as a potential diagnostic biomarker for sepsis: insights from DIA and ELISA analyses7
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors7
Using established biorepositories for emerging research questions: a feasibility study7
Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy7
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?7
Proteomic analysis of 92 circulating proteins and their effects in cardiometabolic diseases7
Correction: Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients6
Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex6
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay6
Circulating proteins as predictive and prognostic biomarkers in breast cancer6
Integrating functional proteomics and next generation sequencing reveals potential therapeutic targets for Taiwanese breast cancer6
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies6
Maternal serum CFHR4 protein as a potential non-invasive marker of ventricular septal defects in offspring: evidence from a comparative proteomics study6
Combination of automated sample preparation and micro-flow LC–MS for high-throughput plasma proteomics6
The effect of storage time and temperature on the proteomic analysis of FFPE tissue sections6
CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds6
Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis6
Proteome profiling of cutaneous leishmaniasis lesions due to dermotropic Leishmania donovani in Sri Lanka6
Proteomics of prostate cancer serum and plasma using low and high throughput approaches6
0.10902094841003